Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Characterization of vascular tortuosity throughout the murine oxygen-induced retinopathy model of ischemic retinopathy
Kyle V. Marra, Tomoya Murakami, Jimmy S. Chen, Edith Aguilar, Jacob Robinson, Maxwell Prenner, Richard Daneman, Martin Friedlander, Eric Nudleman
Kyle V. Marra, Tomoya Murakami, Jimmy S. Chen, Edith Aguilar, Jacob Robinson, Maxwell Prenner, Richard Daneman, Martin Friedlander, Eric Nudleman
View: Text | PDF
Research Article Ophthalmology Vascular biology

Characterization of vascular tortuosity throughout the murine oxygen-induced retinopathy model of ischemic retinopathy

  • Text
  • PDF
Abstract

Vascular tortuosity (VT) is a critical biomarker of disease progression that informs the decision to treat ischemic retinal disorders, particularly retinopathy of prematurity (ROP). The murine oxygen-induced retinopathy (OIR) model is the most widely used model of ischemic retinopathy. Although VT has been described in OIR, its temporal dynamics have not been systematically defined. In this study, a semiautomated artificial intelligence–based (AI-based) pipeline was used to quantify VT throughout OIR. Retinal flat mounts from age-matched normoxic and OIR mice (P10–P56) underwent vessel segmentation using a generative adversarial network (GAN), and VT was quantified as a cumulative tortuosity index with the iROP-Assist algorithm. Concurrently, standard OIR outcomes of neovascularization (NV) and vaso-obliteration (VO) were quantified using the algorithm at http://oirseg.org/. NV peaked at P17 and resolved by P23, while VO regressed over a similar interval. VT peaked with NV at P17 but remained elevated through P56. These temporal changes mirror both the development of VT and its persistence after NV regression observed clinically in ROP. Collectively, these findings establish VT as a durable, quantifiable phenotype in OIR and expand the model’s utility beyond neovascular endpoints, providing a translational platform for investigating VT pathogenesis and evaluating the effects of therapeutic agents on VT.

Authors

Kyle V. Marra, Tomoya Murakami, Jimmy S. Chen, Edith Aguilar, Jacob Robinson, Maxwell Prenner, Richard Daneman, Martin Friedlander, Eric Nudleman

×

Figure 3

Quantification of neovascularization, vaso-obliteration, and vascular tortuosity in OIR and age-matched NOX mice.

Options: View larger image (or click on image) Download as PowerPoint
Quantification of neovascularization, vaso-obliteration, and vascular to...
Mice were sacrificed on P10, daily from P12 to P26, and on P28, P42, and P56. Retinal flat mounts were quantified for (A) NV, (B) VO, and (C) VT. NV peaked at P17 in OIR mice and regressed by P23. VO had developed at P10 in OIR mice and decreased until reaching levels comparable to those of NOX mice at P23. Relative to NOX mice, OIR mice exhibited increased CTI at P10 that peaked at P17. CTI subsequently regressed in OIR mice but remained elevated compared with levels observed in NOX mice, even at P56.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts